Navigation Links
Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas
Date:11/4/2009

BOZEN, Italy, November 4 /PRNewswire/ -- Health Robotics today announced the worldwide presentation and launch of its new i.v.SOFT Workflow Engine at the American Society of Health-System Pharmacists' Mid-Year Meeting December 6-10 in Las Vegas. With the availability of the i.v.SOFT Workflow Engine, Health Robotics becomes the first and only company in the world to provide a total automation solution to fill the void of automated process control and patient safety in the I.V. Room.

i.v.SOFT's Workflow Engine represents a an additional revolutionary step by Health Robotics in completing its vision to fully automate IV Admixtures by providing state-of-the-art software automation tools to address the IV preparation of patient doses that cannot be physically handled by robotics technology due to a variety of reasons, such as hospital choices of ampoules, non-standard IV Bags, diverse Elastomeric infusion devices, etc.

The primary challenges in today's IV Admixture operations are serious medication errors such as drug exchange and accuracy mistakes, high costs, life-critical turn-around time, intravenous drugs waste, regulatory issues, and difficulty in maintaining adequately trained clinical staff. While market-leading robots CytoCare(TM) and i.v.STATION(TM) automatically and aseptically compound the majority of hazardous and non-hazardous IV doses, hospitals have demanded complementary automation solutions for the 20-30% of IV doses (depending on local market requirements) that need to be routed to manual compounding on BSCs (biological safety cabinets). i.v.SOFT Workflow Engine offers worldwide hospital pharmacies the ability to have their pharmacy technicians work more efficiently while at the same time reducing costs due to IV Admixtures that are typically lost or re-made.

"Building the i.v.SOFT Workflow Engine upon the product specifications, customer experience, software logic, and industrial component integration (digital camera, Barcode and RFID technologies, precision scale gravimetric controls, etc.) that we had already utilized for CytoCare and i.v.STATION proved to be a highly-complementary research and development project. I look forward to working with Gaspar DeViedma at the worldwide hospitals he selects for beta testing of the i.v.SOFT Workflow Engine during the first quarter of 2010" stated Fabio Fioravanti, Health Robotics' Chief Software Architect.

"i.v.SOFT Workflow Engine and its optional modules (Dashboard, Profile, Cube, and Interface Engine) represent a very important milestone for Health Robotics as we leap from a niche technology vendor to our vision to become a full solution provider for the I.V. Room, which is the last frontier for modern technology adoption at worldwide hospitals. Our vision to own the I.V. Room Automation market should be complete when we release TPNstation(TM) to the market in late 2010" stated Werner Rainer, Health Robotics' CEO.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, please visit http://www.health-robotics.com

    For additional information, please contact:

    Health Robotics S.r.l.
    Gaspar DeViedma
    Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100
    USA: +1-609-980-7976
    EUROPE: +39-346-963-4934
    gaspar.deviedma@health-robotics.com

Contact: Health Robotics S.r.l., Gaspar DeViedma, Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100, USA: +1-609-980-7976, EUROPE: +39-346-963-4934, gaspar.deviedma@health-robotics.com

SOURCE Health Robotics


'/>"/>
SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ViroPharma to Present at Three November Healthcare Conferences
2. NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference
3. Pragmedic Implements World-Class Healthcare Solution for Emaar Healthcare
4. PDL BioPharma to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009
5. Diabetics: 3tailer Partners with MyGlucoHealth on World's 1st Blood Glucose Meter with Wireless Bluetooth for Diabetes
6. Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs
7. Collaboration of Indianas Health Information Exchanges, State Organizations Submits Application for Health Information Technology Stimulus Funding
8. avVaa World Health Care Products Inc. Announces Access via Social Media Websites
9. Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 Diabetes
10. Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award
11. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
(Date:3/23/2017)... 23, 2017 According to a report by ... market is fragmented due to the presence of a large pool of ... Thermo Fisher , and Sigma-Aldrich, compete with each other in this ... held more than 76% of this market in 2016.  ... As of now, a large ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... , March 22, 2017 Good Start ... it has eclipsed the 130 million covered lives mark ... Shield of Texas . With newly ... Company continues to enjoy strong payor acceptance based on ... clinical programs and genetic counseling, its industry-leading customer care ...
Breaking Biology Technology:
(Date:3/2/2017)... March 2, 2017 Summary This report ... and its partnering interests and activities since 2010. ... Read the full ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ...
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
Breaking Biology News(10 mins):